Principal Investigator
Agustin Pimentel
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20220823
Clinical Trial Summary
A Phase 2/3, Randomized, Open-Label Study of
Maintenance GRT-C901/GRT-R902, A Neoantigen
Vaccine, in Combination with Immune Checkpoint
Blockade for Patients with Metastatic Colorectal Cancer
Phase
Phase II/III
Funding Agency/Sponsor
Industrial
Disease
Colorectal Cancer
Contact Information
Phone Number
305-243-2647